Cite
The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019-2023 update of the patent literature.
MLA
Bernardoni, Bianca Laura, et al. “The Challenging Inhibition of Aldose Reductase for the Treatment of Diabetic Complications: A 2019-2023 Update of the Patent Literature.” Expert Opinion on Therapeutic Patents, vol. 34, no. 11, Nov. 2024, pp. 1085–103. EBSCOhost, https://doi.org/10.1080/13543776.2024.2412573.
APA
Bernardoni, B. L., D’Agostino, I., Scianò, F., & La Motta, C. (2024). The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019-2023 update of the patent literature. Expert Opinion on Therapeutic Patents, 34(11), 1085–1103. https://doi.org/10.1080/13543776.2024.2412573
Chicago
Bernardoni, Bianca Laura, Ilaria D’Agostino, Fabio Scianò, and Concettina La Motta. 2024. “The Challenging Inhibition of Aldose Reductase for the Treatment of Diabetic Complications: A 2019-2023 Update of the Patent Literature.” Expert Opinion on Therapeutic Patents 34 (11): 1085–1103. doi:10.1080/13543776.2024.2412573.